Correlation Between Delpha Construction and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Delpha Construction and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delpha Construction and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Delpha Construction Co and GeneReach Biotechnology, you can compare the effects of market volatilities on Delpha Construction and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delpha Construction with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delpha Construction and GeneReach Biotechnology.

Diversification Opportunities for Delpha Construction and GeneReach Biotechnology

0.0

Correlation Coefficient

Delpha Construction  GeneReach Biotechnology

Pay attention - limited upside

The 3 months correlation between Delpha and GeneReach is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Delpha Construction Co and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Delpha Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delpha Construction Co are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Delpha Construction i.e., Delpha Construction and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Delpha Construction and GeneReach Biotechnology

Assuming the 90 days trading horizon Delpha Construction Co is expected to generate 0.99 times more return on investment than GeneReach Biotechnology. However, Delpha Construction Co is 1.02 times less risky than GeneReach Biotechnology. It trades about 0.1 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.04 per unit of risk. If you would invest  1,720  in Delpha Construction Co on October 4, 2024 and sell it today you would earn a total of  2,180  from holding Delpha Construction Co or generate 126.74% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	99.79%
Values	Daily Returns

Delpha Construction Co  vs.  GeneReach Biotechnology

Delpha Construction

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Delpha Construction Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Delpha Construction is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Delpha Construction and GeneReach Biotechnology

The main advantage of trading using opposite Delpha Construction and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delpha Construction position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Delpha Construction Co and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.